SCHEMBL7232829

SCHEMBL7232829

CCC(CC[C@@H]1C[C@@H](C(=O)O)C[C@H]1NC=NN)C(C)CNC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7242472 1.00 — —
SCHEMBL7236294 0.82 — —
SCHEMBL7240834 0.81 — —
SCHEMBL7233753 0.78 NEU2 (0.34) —
Trifluoroacetic Acid SCHEMBL7240936 0.76 — —
SCHEMBL7237845 0.74 — —
SCHEMBL7234621 0.71 NEU2 (0.42) —
SCHEMBL7233107 0.71 NEU2 (0.42) —
SCHEMBL7242025 0.71 NEU2 (0.42) —
SCHEMBL7231650 0.71 NEU2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562861-B1 (1R,3R,4R,1'S)-(-)-(1'-acetylamino-2 '-ethyl)butyl-4-(aminoimino)methylaminocyclopentan-1-carboxylic acid was prepd. and tested in vitro as neuraminidase inhibitor (IC50 less-than 1.mu.M). Bactericides or viricides BIOCRYST PHARMACEUTICALS, INC. 2003-05-13 — — US claimed
US-6562861-B1 (1R,3R,4R,1'S)-(-)-(1'-acetylamino-2 '-ethyl)butyl-4-(aminoimino)methylaminocyclopentan-1-carboxylic acid was prepd. and tested in vitro as neuraminidase inhibitor (IC50 less-than 1.mu.M). Bactericides or viricides BIOCRYST PHARMACEUTICALS, INC. 2003-05-13 — — US disclosed
Send feedback